Safety and Preliminary Signs of Efficacy of F8IL10 for Intra-articular Treatment

Stopped Study redesigned and registered under NCT07245992 (Protocol n° PH-F8IL10INTRA-03/24)

Conditions

• Rheumatoid Arthritis

Interventions

• DRUG: F8IL10

Sponsor

Philogen S.p.A.